Showing results (281-290 of 2,117) with videos related to
Sort By:
Pageof 212
International Clinical Psychopharmacology|May 24, 2007
Similar frequency of abnormal correlation between serum leptin levels and BMI before and after olanzapine treatment in schizophreniaTrino Baptista, Adriana Dávila, Yamily El Fakih, et al.International Clinical Psychopharmacology|May 24, 2007
Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective studyCorrado Barbui, Bruno Biancosino, Eleonora Esposito, et al.International Clinical Psychopharmacology|May 24, 2007
D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorderEric A Storch, Lisa J Merlo, Michael Bengtson, et al.International Clinical Psychopharmacology|April 7, 2007
Serotonin transporter polymorphisms and the occurrence of adverse events during treatment with selective serotonin reuptake inhibitorsKim Smits, Luc Smits, Frenk Peeters, et al.International Clinical Psychopharmacology|April 7, 2007
Antidepressant prophylaxis for poststroke depression: a meta-analysisYan Chen, Nick C Patel, Jeff J Guo, et al.International Clinical Psychopharmacology|May 12, 2006
Treatment of paraphilic sexual disorder: the use of topiramate in fetishismI-Shin Shiah, Che-Yi Chao, Wei-Chung Mao, et al.International Clinical Psychopharmacology|May 12, 2006
Priapism associated with typical and atypical antipsychotic medicationsChien-Shu Wang, Wei-Tsung Kao, Chian-Dar Chen, et al.International Clinical Psychopharmacology|April 23, 2004
Treatment of Huntington's disease with galantamineP Petrikis, C Andreou, A Piachas, et al.International Clinical Psychopharmacology|June 1, 1992
Clinical pharmacokinetics of citalopram and other selective serotonergic reuptake inhibitors (SSRI)P BaumannInternational Clinical Psychopharmacology|June 1, 1992
Citalopram in depression--meta-analysis of intended and unintended effectsP Bech, P CialdellaPageof 212